Neogenomics plunges as BioReference Labs makes another acquisition

|By:, SA News Editor

While correlation doesn't necessarily imply causation, it's probably worth noting that today's action in shares of Neogenomics (NEO -8.4%) mirrors the stock's dismal performance from last Tuesday.

The connection: Peer BioReference Laboratories (BRLI +2.5%) announced "strategic acquisitions" both today and on August 13.